Medpace Holdings, Inc. Increase (Decrease) in Accounts Payable
Medpace Holdings, Inc. (MEDP) reported Increase (Decrease) in Accounts Payable of -$45.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-07-23
- Medpace Holdings, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$129.00K, a 109.92% decline year-over-year.
- Medpace Holdings, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $84.00K, a 99.22% decline year-over-year.
- Medpace Holdings, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $1.33M, a 1982.81% increase year-over-year.
- Medpace Holdings, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$10.72M.
- Medpace Holdings, Inc. increase (decrease) in accounts payable for fiscal 2025 was $2.63M.
- Medpace Holdings, Inc. increase (decrease) in accounts payable for fiscal 2024 was -$2.96M, a 382.11% decline from fiscal 2023.
- Medpace Holdings, Inc. increase (decrease) in accounts payable for fiscal 2023 was $1.05M, a 83.66% decline from fiscal 2022.
- Medpace Holdings, Inc. increase (decrease) in accounts payable for fiscal 2022 was $6.43M, a 244.64% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$129.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | -$45.00K 10-Q · filed 2026-07-23 | $1.29M derived: sum of 3 quarters · filed 2026-07-23 | -$9.44M derived: sum of 4 quarters · filed 2026-07-23 |
| 2026-03-31 | $84.00K 10-Q · filed 2026-04-23 | $1.42M derived: sum of 2 quarters · filed 2026-04-23 | -$9.31M derived: sum of 3 quarters · filed 2026-04-23 | -$8.01M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-12-31 | $1.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | -$9.39M derived: sum of 2 quarters · filed 2026-02-10 | -$8.09M derived: sum of 3 quarters · filed 2026-07-23 | $2.63M 10-K · filed 2026-02-10 |
| 2025-09-30 | -$10.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | -$9.42M derived: sum of 2 quarters · filed 2026-07-23 | $1.30M 10-Q · filed 2025-10-23 | $1.36M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-06-30 | $1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | $12.02M 10-Q · filed 2026-07-23 | $12.09M derived: sum of 3 quarters · filed 2026-07-23 | $11.51M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-03-31 | $10.72M 10-Q · filed 2026-04-23 | $10.78M derived: sum of 2 quarters · filed 2026-04-23 | $10.21M derived: sum of 3 quarters · filed 2026-04-23 | $15.11M derived: sum of 4 quarters · filed 2026-04-23 |
| 2024-12-31 | $64.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | -$512.00K derived: sum of 2 quarters · filed 2026-02-10 | $4.39M derived: sum of 3 quarters · filed 2026-02-10 | -$2.96M 10-K · filed 2026-02-10 |
| 2024-09-30 | -$576.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | $4.32M derived: sum of 2 quarters · filed 2025-10-23 | -$3.03M 10-Q · filed 2025-10-23 | -$1.06M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-06-30 | $4.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-22 | -$2.45M 10-Q · filed 2025-07-22 | -$481.00K derived: sum of 3 quarters · filed 2026-02-10 | -$3.74M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-31 | -$7.35M 10-Q · filed 2025-04-22 | -$5.38M derived: sum of 2 quarters · filed 2026-02-10 | -$8.64M derived: sum of 3 quarters · filed 2026-02-10 | -$10.76M derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-31 | $1.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | -$1.29M derived: sum of 2 quarters · filed 2026-02-10 | -$3.41M derived: sum of 3 quarters · filed 2026-02-10 | $1.05M 10-K · filed 2026-02-10 |
| 2023-09-30 | -$3.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-22 | -$5.38M derived: sum of 2 quarters · filed 2024-10-22 | -$921.00K 10-Q · filed 2024-10-22 | $4.74M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-06-30 | -$2.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-23 | $2.34M 10-Q · filed 2024-07-23 | $8.00M derived: sum of 3 quarters · filed 2025-02-11 | $6.22M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-03-31 | $4.46M 10-Q · filed 2024-04-23 | $10.12M derived: sum of 2 quarters · filed 2025-02-11 | $8.34M derived: sum of 3 quarters · filed 2025-02-11 | $11.93M derived: sum of 4 quarters · filed 2025-02-11 |
| 2022-12-31 | $5.66M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | $3.88M derived: sum of 2 quarters · filed 2025-02-11 | $7.47M derived: sum of 3 quarters · filed 2025-02-11 | $6.43M 10-K · filed 2025-02-11 |
| 2022-09-30 | -$1.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-24 | $1.81M derived: sum of 2 quarters · filed 2023-10-24 | $770.00K 10-Q · filed 2023-10-24 | $486.00K derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-06-30 | $3.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-25 | $2.55M 10-Q · filed 2023-07-25 | $2.27M derived: sum of 3 quarters · filed 2024-02-13 | $4.69M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-03-31 | -$1.04M 10-Q · filed 2023-04-25 | -$1.32M derived: sum of 2 quarters · filed 2024-02-13 | $1.09M derived: sum of 3 quarters · filed 2024-02-13 | $3.46M derived: sum of 4 quarters · filed 2024-02-13 |
| 2021-12-31 | -$284.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $2.14M derived: sum of 2 quarters · filed 2024-02-13 | $4.50M derived: sum of 3 quarters · filed 2024-02-13 | $1.87M 10-K · filed 2024-02-13 |
| 2021-09-30 | $2.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-25 | $4.79M derived: sum of 2 quarters · filed 2022-10-25 | $2.15M 10-Q · filed 2022-10-25 | $5.16M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | $2.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-26 | -$270.00K 10-Q · filed 2022-07-26 | $2.74M derived: sum of 3 quarters · filed 2023-02-14 | $4.31M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | -$2.64M 10-Q · filed 2022-04-26 | $376.00K derived: sum of 2 quarters · filed 2023-02-14 | $1.94M derived: sum of 3 quarters · filed 2023-02-14 | $1.57M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | $3.01M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $4.58M derived: sum of 2 quarters · filed 2023-02-14 | $4.21M derived: sum of 3 quarters · filed 2023-02-14 | -$2.60M 10-K · filed 2023-02-14 |
| 2020-09-30 | $1.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-26 | $1.20M derived: sum of 2 quarters · filed 2021-10-26 | -$5.61M 10-Q · filed 2021-10-26 | -$3.70M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | -$364.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-27 | -$7.17M 10-Q · filed 2021-07-27 | -$5.26M derived: sum of 3 quarters · filed 2022-02-15 | -$7.78M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | -$6.81M 10-Q · filed 2021-04-27 | -$4.90M derived: sum of 2 quarters · filed 2022-02-15 | -$7.42M derived: sum of 3 quarters · filed 2022-02-15 | $605.00K derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | $1.91M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | -$608.00K derived: sum of 2 quarters · filed 2022-02-15 | $7.41M derived: sum of 3 quarters · filed 2022-02-15 | $4.73M 10-K · filed 2022-02-15 |
| 2019-09-30 | -$2.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-27 | $5.50M derived: sum of 2 quarters · filed 2020-10-27 | $2.82M 10-Q · filed 2020-10-27 | $5.48M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-06-30 | $8.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-28 | $5.34M 10-Q · filed 2020-07-28 | $8.00M derived: sum of 3 quarters · filed 2021-02-16 | $5.30M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-03-31 | -$2.68M 10-Q · filed 2020-04-29 | -$19.00K derived: sum of 2 quarters · filed 2021-02-16 | -$2.72M derived: sum of 3 quarters · filed 2021-02-16 | -$2.04M derived: sum of 4 quarters · filed 2021-02-16 |
| 2018-12-31 | $2.67M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | -$33.00K derived: sum of 2 quarters · filed 2021-02-16 | $643.00K derived: sum of 3 quarters · filed 2021-02-16 | $1.34M 10-K · filed 2021-02-16 |
| 2018-09-30 | -$2.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29 | -$2.02M derived: sum of 2 quarters · filed 2019-10-29 | -$1.32M 10-Q · filed 2019-10-29 | $3.96M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $676.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-30 | $1.38M 10-Q · filed 2019-07-30 | $6.66M derived: sum of 3 quarters · filed 2020-02-25 | $9.05M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $699.00K 10-Q · filed 2019-04-30 | $5.98M derived: sum of 2 quarters · filed 2020-02-25 | $8.37M derived: sum of 3 quarters · filed 2020-02-25 | $6.85M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $5.28M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $7.67M derived: sum of 2 quarters · filed 2020-02-25 | $6.15M derived: sum of 3 quarters · filed 2020-02-25 | $4.82M 10-K · filed 2020-02-25 |
| 2017-09-30 | $2.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $864.00K derived: sum of 2 quarters · filed 2018-10-30 | -$467.00K 10-Q · filed 2018-10-30 | $1.17M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | -$1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | -$2.85M 10-Q · filed 2018-07-31 | -$1.22M derived: sum of 3 quarters · filed 2019-02-26 | -$52.00K derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | -$1.33M 10-Q · filed 2018-05-01 | $303.00K derived: sum of 2 quarters · filed 2019-02-26 | $1.47M derived: sum of 3 quarters · filed 2019-02-26 | $1.39M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $2.80M derived: sum of 2 quarters · filed 2019-02-26 | $2.72M derived: sum of 3 quarters · filed 2019-02-26 | $691.00K 10-K · filed 2019-02-26 |
| 2016-09-30 | $1.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $1.08M derived: sum of 2 quarters · filed 2017-10-31 | -$943.00K 10-Q · filed 2017-10-31 | $692.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | -$85.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | -$2.11M 10-Q · filed 2017-08-01 | -$477.00K derived: sum of 3 quarters · filed 2018-02-27 | |
| 2016-03-31 | -$2.03M 10-Q · filed 2017-05-02 | -$392.00K derived: sum of 2 quarters · filed 2018-02-27 | ||
| 2015-12-31 | $1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $2.48M 10-K · filed 2018-02-27 | ||
| 2015-09-30 | $846.00K 10-Q · filed 2016-11-03 | |||
| 2014-12-31 | $558.00K 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |